Asthma Bronchial Hypereosinophilic

Bronchial asthma (Latin asthma bronchiale; English bronchial asthma; synonym allergic asthma, exercise intolerance, asthmatic bronchitis) is a chronic allergic disease characterized by periodic attacks of expiratory shortness of breath and/or wheezing against a background of diffuse spastic

Bronchodial hypertrophic asthma is a pathological process that occurs in the bronchial cavity, during which persistent morphological changes occur in their wall. They are formed as a result of an allergic or infectious lesion of the lower respiratory tract and are present for many years.

The formation of bronchial asthma is a long process and is accompanied by continuous exacerbations and relapses of the disease. The disease is chronic, characterized by periodic attacks lasting up to two days and is accompanied by characteristic respiratory symptoms. In the absence of treatment or its ineffectiveness, there is a risk of developing severe complications, such as pulmonary embolism, respiratory arrest with subsequent death of the patient. With severe asthma, the risk of complications increases fivefold. That is why it is necessary to prevent relapses of the disease and constant contact of a sick person with allergens. In addition, adequate treatment is needed, the selection of which should be carried out under the supervision of a specialist. This is the only way to achieve a significant improvement in the patient’s condition, completely eliminate the clinical manifestations of the disease and prevent the possibility of complications.